Pieris Pharmaceuticals(PIRS) - 2019 Q3 - Earnings Call Transcript

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q3 2019 Results Earnings Conference Call November 11, 2019 8:00 AM ET Company Participants Thomas Bures - Principal Financial & Accounting Officer and Treasurer 2 Stephen Yoder - CEO, President Ingmar Bruns - VP, Clinical Development Shane Olwill - VP, Head:Development Conference Call Participants John Miller - Evercore ISI Joe Pantginis - H.C. Wainwright Madhu Kumar - Robert W. Baird Chris Shibutani - Cowen Biren Amin - Jeffries Umer Raffat - Evercore Matt Phipps ...